It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.
Hover or tap a dot to see the filings behind that score.
Applied Therapeutics, Inc. (the “ Company ”) is unable to complete the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “ Form 10-K ”) within the prescribed time period without unreasonable effort or expense as the Company is still preparing analyses to complete its procedures relating to its year-end financial reporting process. The Company is working diligently to complete such tasks. The Company expects to file the Form 10-K within the fifteen calendar-day period permitted pursuant to Rule 12b-25. In connection with its assessment of internal control over financial reporting as of December 31, 2024, management has concluded that the Company’s internal control over financial reporting was not effective, as management identified a material weakness related to deficiencies in the principles associated with the information and communication component of the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). The Form 10-K will further describe this material weakness, and the steps the Company has and is taking to remediate this material weakness
NT 10-K, filed 2025-03-31 · material weakness
Applied Therapeutics, Inc. (the “ Company ”) is unable to complete the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “ Form 10-K ”) within the prescribed time period without unreasonable effort or expense as the Company is still preparing analyses to complete its procedures relating to its year-end financial reporting process. The Company is working diligently to complete such tasks. The Company expects to file the Form 10-K within the fifteen calendar-day period permitted pursuant to Rule 12b-25. In connection with its assessment of internal control over financial reporting as of December 31, 2024, management has concluded that the Company’s internal control over financial reporting was not effective, as management identified a material weakness related to deficiencies in the principles associated with the information and communication component of the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). The Form 10-K will further describe this material weakness, and the steps the Company has and is taking to remediate this material weakness
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice